QUINOLINONE DERIVATIVES AS PARP AND TANK INHIBITORS
申请人:Vialard Jorge Eduardo
公开号:US20100168065A1
公开(公告)日:2010-07-01
The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I)
wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, n, m and X have defined meanings.
QUINOLINONE DERIVATIVES AS PARP INHIBITORS
申请人:Angibaud Patrick René
公开号:US20100222348A1
公开(公告)日:2010-09-02
Compounds of formula (I):
wherein R
1
, R
2
, R
3
, R
4
, R
5
, Z and n have defined meanings, the N-oxide forms, the pharmaceutically acceptable addition salts, the quaternary ammonium salts and the stereochemically isomeric forms thereof, and their use for the treatment of PARP-mediated disorders.